Open | - |
Close | - |
Volume / Avg. | 0 / 641.870K |
Day Range | - - - |
52 Wk Range | 0.575 - 1.790 |
Market Cap | $77.955M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 0.57% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Passage Bio (NASDAQ: PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), CARISMA Therapeutics (NASDAQ:CARM) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Passage Bio (NASDAQ: PASG) was reported by Canaccord Genuity on Tuesday, March 5, 2024. The analyst firm set a price target for 14.00 expecting PASG to rise to within 12 months (a possible 898.50% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Passage Bio (NASDAQ: PASG) is $1.4021 last updated March 18, 2024 at 5:35 PM EDT.
There are no upcoming dividends for Passage Bio.
Passage Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Passage Bio.
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.